fungal keratitis

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acanthamoeba Keratitis, Fungal Keratitis Trial in Madurai (Moxifloxacin Ophthalmic, Chlorhexidine Gluconate, Natamycin)

Recruiting
  • Acanthamoeba Keratitis
  • Fungal Keratitis
  • Moxifloxacin Ophthalmic
  • +4 more
  • Madurai, Tamil Nadu, India
    Aravind Eye Care System
Jan 8, 2023

Antimicrobial Regimens in Microbial Keratitis: A Prospective

Recruiting
  • Bacterial Keratitis
  • +3 more
  • Moxifloxacin Ophthalmic 0.5% Ophthalmic Solution
  • +7 more
  • Alexandria, Egypt
    Cornea Outpatient Clinic at Alexandria Main University Hospital
Dec 15, 2022

Corneal Ulcer, Fungal Keratitis Trial in San Francisco, Pondicherry (Intrastromal voriconazole, Natamycin)

Completed
  • Corneal Ulcer
  • Fungal Keratitis
  • San Francisco, California
  • +1 more
Sep 12, 2019

Fungal Keratitis Trial in Kaohsiung, Taipei (Lamellar keratoplasty-ABCcolla® Collagen Ophthalmic Matrix)

Unknown status
  • Fungal Keratitis
  • Lamellar keratoplasty-ABCcolla® Collagen Ophthalmic Matrix
  • Kaohsiung, Taiwan
  • +3 more
Aug 12, 2019

Fungal Keratitis Trial in Madurai, Pondicherry (Natamycin 5%, Voriconazole, Corneal de-epithelialization)

Completed
  • Fungal Keratitis
  • Natamycin 5%
  • +2 more
  • Madurai, Tamil Nadu, India
  • +1 more
Jul 9, 2018

Bacterial Keratitis, Fungal Keratitis Trial in Nantes (Crosslinking, antibiotic treatment)

Terminated
  • Bacterial Keratitis
  • Fungal Keratitis
  • Crosslinking
  • antibiotic treatment
  • Nantes, France
    Orignac
May 31, 2017

Infectious Keratitis, Bacterial Keratitis, Fungal Keratitis Trial in Pratumwan (Collagen cross-linking)

Completed
  • Infectious Keratitis
  • +2 more
  • Collagen cross-linking
  • Pratumwan, Bangkok, Thailand
    Ophthalmology department, King Chulalongkorn Memorial hospital
May 1, 2015

Fungal Keratitis Trial (povidone-iodine 1.25% ophthalmic solution, natamycin ophthalmic suspension, USP 5%)

Terminated
  • Fungal Keratitis
  • povidone-iodine 1.25% ophthalmic solution
  • natamycin ophthalmic suspension, USP 5%
  • (no location specified)
Dec 3, 2014